J9217 HCPCS Level II code: Leuprolide acetate (for depot suspension), 7.5 mg
J9217 is the HCPCS code for “Leuprolide acetate (for depot suspension), 7.5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9217Leuprolide acetate (for depot suspension), 7.5 mg
Short description: Leuprolide acetate suspnsion
HCPCS · United States
Medicare details
The indicators CMS publishes with J9217 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1991
Where J9217 sits
- 1J codesDrugs administered other than orally
- 2Active code J9217Leuprolide acetate (for depot suspension), 7.5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9217 mean?
J9217 is the HCPCS code for “Leuprolide acetate (for depot suspension), 7.5 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9217?
CMS lists J9217’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9217
All J codesJ9211Injection, idarubicin hydrochloride, 5 mgJ9212Injection, interferon alfacon-1, recombinant, 1 microgramJ9213Injection, interferon, alfa-2a, recombinant, 3 million unitsJ9214Injection, interferon, alfa-2b, recombinant, 1 million unitsJ9215Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iuJ9216Injection, interferon, gamma 1-b, 3 million unitsJ9218Leuprolide acetate, per 1 mgJ9219Leuprolide acetate implant, 65 mgJ9220Injection, indigotindisulfonate sodium, 1 mgJ9223Injection, lurbinectedin, 0.1 mgJ9225Histrelin implant (vantas), 50 mgJ9226Histrelin implant (supprelin la), 50 mg